+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases



Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases



Antimicrobial Agents and ChemoTherapy 42(1): 53-58



An outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-KP) was detected from May 1993 to June 1995. A total of 145 patients, particularly patients in intensive care units (ICUs) (107 patients [72%]), were colonized or infected. Infection developed in 92 (63%) patients, and primary bacteremia caused by ESBL-KP was the most frequent infection (40 of 92 patients [43%]). A single clone of ESBL-KP was identified by pulsed-field gel electrophoresis analysis throughout the whole period, and no molecular epidemiological relationship could be found between the epidemic strain and non-ESBL-KP isolates. To determine risk factors for ESBL-KP infection weekly rectal swabs were obtained in three serial incidence surveys (470 patients); the probabilities of carriage of ESBL-KP in the digestive tract were 33% (October and November 1993), 40% (May and June 1994), and 0% (October and November 1995) at 10 days of ICU admission. A logistic regression model identified prior carriage of ESBL-KP in the digestive tract (odds ratio, 3.4; 95% confidence interval 1.1 to 10.4) as an independent variable associated with ESBL-KP infection. A statistically significant correlation was observed between the restricted use of oxyimino-beta-lactams (189 defined daily doses [DDD]/ 1,000 patient-days to 24 DDD/1,000 patient-days) and the trends of ESBL-KP infection (r = 0.7; P = 0.03).

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008616755

Download citation: RISBibTeXText

PMID: 9449260


Related references

Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum -Lactamases. Antimicrobial Agents and Chemotherapy 42(1): 53-58, 1998

Impact of third-generation cephalosporins restriction on the control of an extended-spectrum beta-lactamases producing Klebsiella pneumoniae outbreak in ICU. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 222, 1996

First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea. Antimicrobial Agents and ChemoTherapy 49(11): 4809-4810, 2005

An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: The importance of using cefpodoxime to detect extended-spectrum beta-lactamases. Journal of Antimicrobial Chemotherapy 51(1): 195-196, 2003

Molecular epidemiology of nosocomial infection by extended-spectrum beta-lactamases-producing Klebsiella pneumoniae. Biomedica 24(3): 252-261, 2004

Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum beta-lactamases. Journal of Hospital Infection 72(1): 23-29, 2009

Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection. Clinical Infectious Diseases 35(7): 834-841, 2002

Incidence of extended-spectrum beta-lactamases and characterization of integrons in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Shantou, China. Acta Biochimica et Biophysica Sinica 39(7): 527-532, 2007

Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases. Diagnostic Microbiology and Infectious Disease 61(3): 343-345, 2008

Characterization of Klebsiella pneumoniae strains producing extended spectrum beta-lactamases and AMPC type beta-lactamases isolated from hospitalized patients in Kerman, Iran. Roumanian Archives of Microbiology and Immunology 71(2): 81-86, 2012

Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: control of an outbreak using a new ADSRRS technique. Polish Journal of Microbiology 54(2): 105-110, 2005

Detection of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Abstracts of the General Meeting of the American Society for Microbiology 98: 134, 1998

Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases. Revista Medica de Chile 132(10): 1173-1178, 2004

Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases. Antimicrobial Agents and ChemoTherapy 55(5): 2434-2437, 2011

Molecular epidemiology of Klebsiella pneumoniae with extended-spectrum beta-lactamases in Brooklyn, NY. Clinical Infectious Diseases 31(1): 227, 2000